Clinicopathological Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network

By N. U. Lin, A. Vanderplas, M. Hughes, R. Theriault, Stephen B. Edge, Y. Wong, Douglas W. Blayney, J. Niland, Eric P. Winer, Jane C. Weeks. Cancer, 2012

631 citations recorded by the source corpus.

The objective of this study was to describe clinicopathologic features, patterns of recurrence, and survival according to breast cancer subtype with a focus on triple‐negative tumors.

Subfields: Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/64899eaf61830896ec52686ba61cd7a132fb9833

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Kathleen A. Cronin
2. S. Altekruse
3. N. Howlader
4. Christopher I. Li
5. L. Ries
6. C. Clarke
7. V. Chen
8. R. Siegel

Citations in the corpus

• US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. (2014, result): “Using HR + /HER2 − as the comparison group in these analyses, little difference was found in the stage distribution of triple-negative case patients, unlike prior studies (29,33); however, triple-negative case patients were substantially more likely to have high-grade cancer (17% vs 75”